Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Non-Current Assets: 2014-2025

Historic Other Non-Current Assets for AC Immune (ACIU) over the last 7 years, with Sep 2025 value amounting to $730,043.

  • AC Immune's Other Non-Current Assets rose 52.41% to $730,043 in Q3 2025 from the same period last year, while for Sep 2025 it was $730,043, marking a year-over-year increase of 52.41%. This contributed to the annual value of $730,043 for FY2025, which is N/A change from last year.
  • As of Q3 2025, AC Immune's Other Non-Current Assets stood at $730,043, which was up 103,392.37% from $705.41 recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Other Non-Current Assets peaked at $398.1 million during Q2 2021, and registered a low of $473.73 during Q4 2024.
  • Its 3-year average for Other Non-Current Assets is $400,248, with a median of $408,707 in 2023.
  • As far as peak fluctuations go, AC Immune's Other Non-Current Assets surged by 126,077.31% in 2021, and later slumped by 99.91% in 2022.
  • Quarterly analysis of 5 years shows AC Immune's Other Non-Current Assets stood at $393,674 in 2021, then dropped by 4.81% to $374,726 in 2022, then climbed by 8.61% to $406,975 in 2023, then plummeted by 99.88% to $473.73 in 2024, then surged by 52.41% to $730,043 in 2025.
  • Its Other Non-Current Assets was $730,043 in Q3 2025, compared to $705.41 in Q2 2025 and $650,667 in Q1 2025.